Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenoxymethylpenicillin for GAS-negative Tonsillitis
NCT04083417Phase 4Recruiting
- Start
- Sep 2019
- Primary completion
- Jun 2026
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phenoxymethylpenicillin in acute tonsillitis (2 arms). Primary endpoint: Differences in number of days from inclusion to resolution of symptoms at 10 days. Started Sep 2019; status: recruiting.
02
Drugs
phenoxymethylpenicillin
03
Conditions
acute tonsillitis
Beyond the preview
Go deeper on NCT04083417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083417.